Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT07492641

1 development in the corpus

NCT07492641

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 19, 2026 · PHASE 3 TRIAL

BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease

ClinicalTrials.gov

This is an active Phase 3 trial registration with no results posted; the study is still recruiting and outcomes are not yet reported.

PreliminaryPalbociclib BeOne Medicines Letrozole

Reported

PhasePhase 3

Planned enrollment1056

Primary outcome measureProgression-Free Survival (PFS) Determined…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support